Sun Ying

Biography

Dr. Sun Ying MD, PhD, is an advisor of master's degree student and winner of the Youth Talent Training Program of Sun Yat-sen University Cancer Center (2009). She received the Doctoral degree in Imaging and Nuclear Medicine from the Second Affiliated Hospital, Sun Yat-sen University in 2002. She has been working in Radiation Oncology at Sun Yat-sen University Cancer Center since then, focusing both on clinical and scientific research work. She specializes in clinical diagnosis, radiation therapy and combination therapy of head and neck cancer, especially nasopharynx carcinoma. She has published 11 SCI papers as the lead author or corresponding author on mainstream journals including Int J Radiat Oncol Biol Phys (IF: 4.3), Radiother Oncol (IF: 4.5), Plos One (IF: 3.7), BMC Cancer (IF: 3.3), etc.

Research Interest

1. General program of National Natural Science Foundation of China: Study on individualized CTV of nasopharynx carcinoma based on imaging and molecular biology (2011-2013, the first leader)2. General program of National Natural Science Foundation of China: Study on mechanism of regulating and controlling E-cadherin expression by promoter methylation of candidate tumor suppressor gene KRAB-ZNF671 in the process of metastasis of nasopharynx carcinoma (2014--2017, the first leader)3. Program of Guangdong Provincial Department of Science and Technology: Prospective study on IMRT individualized CTV of nasopharynx carcinoma based on principles of MRI (2010--2012, the first leader)4. Program of Guangdong Natural Science Foundation: Studies on significance and function of nasopharynx carcinoma prognosis (2011--2013, the first leader)5. Program of Guangdong Natural Science Foundation: Studies on the biological function and clinical significance of candidate tumor suppressor gene KRAB-ZNF671 in nasopharynx carcinoma (2013--2015, the first leader)6. Talent Program of Sun Yat-sen University Cancer Center (2009--2013, the first leader)7. Sun Yat-Sen University Clinical Research 5010 Program: Study on individualized CTV of nasopharynx carcinoma based on risk map of lesions caused (2013--2022, the first leader)8. Key Clinical Program of the Ministry of Health: Perspective studies on nasopharynx carcinoma prognosis model and TPF induction chemotherapy based on IMRT (2010--2013, the second leader)